Collectively, these results indicate that mutp53 enhances STAT3 signaling activation in PCa by competitively binding to p-STAT3, inhibiting its dephosphorylation by SHP1 and thus promoting oncogenic processes. The gene discussed is STAT3; the disease is posterior cortical atrophy.